14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.98 $159.34 Thursday, 25th Apr 2024 ALNY stock ended at $143.71. This is 0.0626% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.67% from a day low at $141.98 to a day high of $145.77.
90 days $141.98 $184.29
52 weeks $141.98 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Nov 30, 2023 $165.53 $169.65 $165.53 $168.25 719 566
Nov 29, 2023 $161.79 $164.19 $160.18 $164.01 583 567
Nov 28, 2023 $158.09 $161.78 $156.52 $161.36 376 066
Nov 27, 2023 $162.39 $162.50 $159.02 $159.20 628 352
Nov 24, 2023 $162.76 $166.23 $162.27 $162.92 142 980
Nov 22, 2023 $165.20 $167.50 $161.51 $162.88 299 369
Nov 21, 2023 $164.92 $166.54 $161.33 $163.68 484 925
Nov 20, 2023 $163.82 $170.83 $163.38 $165.26 511 816
Nov 17, 2023 $168.54 $169.59 $163.37 $163.73 654 477
Nov 16, 2023 $171.10 $171.99 $167.50 $168.97 433 740
Nov 15, 2023 $169.22 $174.00 $169.22 $171.05 455 332
Nov 14, 2023 $169.97 $172.42 $168.52 $169.99 721 904
Nov 13, 2023 $161.95 $165.06 $159.51 $165.01 334 190
Nov 10, 2023 $165.33 $166.55 $157.84 $161.89 658 706
Nov 09, 2023 $169.14 $169.61 $163.03 $164.52 605 477
Nov 08, 2023 $170.67 $170.67 $166.13 $169.40 496 292
Nov 07, 2023 $168.92 $172.98 $167.57 $170.20 636 035
Nov 06, 2023 $168.99 $169.22 $164.35 $167.15 492 151
Nov 03, 2023 $164.68 $169.12 $164.21 $167.35 653 400
Nov 02, 2023 $162.34 $163.27 $148.73 $161.53 753 809
Nov 01, 2023 $151.94 $157.21 $149.29 $157.00 785 623
Oct 31, 2023 $150.00 $152.26 $148.27 $151.80 574 548
Oct 30, 2023 $151.47 $155.94 $150.84 $151.41 605 862
Oct 27, 2023 $154.18 $154.95 $151.17 $151.76 623 796
Oct 26, 2023 $159.49 $159.51 $155.26 $155.66 637 112
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT